Process of care and outcomes in peripheral arterial disease

被引:15
作者
Collins, TC
Beyth, RJ
机构
[1] Houston VAMC, Houston Ctr Qual Care & Utilizat Studies, Houston, TX 77030 USA
[2] Baylor Coll Med, Div Hlth Serv Res, Houston, TX 77030 USA
关键词
process of care; outcomes; peripheral arterial disease;
D O I
10.1097/00000441-200303000-00005
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Peripheral arterial disease (PAD) is a prevalent illness that most commonly affects patients older than 60 years. As the population ages, the prevalence of PAD and its associated, adverse outcomes will also increase. Adverse outcomes in PAD are either systemic (ie, cardiovascular events such as myocardial infarctions or strokes) or localized to the legs (ie, bypass surgery or amputation). Although much research has focused on adverse systemic outcomes in patients with PAD, less is known about those factors related to adverse limb events. The Centers for Disease Control and Prevention estimate that more than 100,000 amputations are performed in the United States each year. What remains to be determined is the association between how physicians manage patients with PAD (ie, process of care) and the development of adverse limb outcomes. Determining the association of the management of PAD with adverse limb outcomes will highlight those areas in which to focus to improve the quality of care for patients with this disease. Understanding the relationship between risk factors, process of care, and outcomes will be of importance to patients, clinicians, and policy makers.. The purpose of this article is to review the burden of PAD and to discuss the association of process of care with adverse limb outcomes in patients with PAD.
引用
收藏
页码:125 / 134
页数:10
相关论文
共 78 条
[1]   PREVALENCE OF ATHEROTHROMBOTIC BRAIN INFARCTION, CORONARY-ARTERY DISEASE AND PERIPHERAL ARTERIAL-DISEASE IN ELDERLY BLACKS, HISPANICS AND WHITES [J].
ARONOW, WS .
AMERICAN JOURNAL OF CARDIOLOGY, 1992, 70 (13) :1212-1213
[2]   EFFECTS OF COLESTIPOL-NIACIN THERAPY ON HUMAN FEMORAL ATHEROSCLEROSIS [J].
BLANKENHORN, DH ;
AZEN, SP ;
CRAWFORD, DW ;
NESSIM, SA ;
SANMARCO, ME ;
SELZER, RH ;
SHIRCORE, AM ;
WICKHAM, EC .
CIRCULATION, 1991, 83 (02) :438-447
[3]  
Brothers T E, 1997, Cardiovasc Surg, V5, P26, DOI 10.1016/S0967-2109(96)00073-7
[4]   Diabetes mellitus is the major risk factor for African Americans who undergo peripheral bypass graft operation [J].
Brothers, TE ;
Robison, JG ;
Elliott, BM .
JOURNAL OF VASCULAR SURGERY, 1999, 29 (02) :352-359
[5]  
Collins TC, 2002, MED CARE, V40, P106
[6]   PERIPHERAL ARTERIAL-DISEASE IN LARGE VESSELS IS EPIDEMIOLOGICALLY DISTINCT FROM SMALL VESSEL DISEASE - AN ANALYSIS OF RISK-FACTORS [J].
CRIQUI, MH ;
BROWNER, D ;
FRONEK, A ;
KLAUBER, MR ;
COUGHLIN, SS ;
BARRETTCONNOR, E ;
GABRIEL, S .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (06) :1110-1119
[7]   THE SENSITIVITY, SPECIFICITY, AND PREDICTIVE VALUE OF TRADITIONAL CLINICAL-EVALUATION OF PERIPHERAL ARTERIAL-DISEASE - RESULTS FROM NONINVASIVE TESTING IN A DEFINED POPULATION [J].
CRIQUI, MH ;
FRONEK, A ;
KLAUBER, MR ;
BARRETTCONNOR, E ;
GABRIEL, S .
CIRCULATION, 1985, 71 (03) :516-522
[8]   THE PREVALENCE OF PERIPHERAL ARTERIAL-DISEASE IN A DEFINED POPULATION [J].
CRIQUI, MH ;
FRONEK, A ;
BARRETTCONNOR, E ;
KLAUBER, MR ;
GABRIEL, S ;
GOODMAN, D .
CIRCULATION, 1985, 71 (03) :510-515
[9]  
CRONENWETT JL, 1984, ARCH SURG-CHICAGO, V119, P430
[10]  
De Frang R D, 1991, Ann Vasc Surg, V5, P202, DOI 10.1007/BF02016758